Virtu Financial LLC Checkpoint Therapeutics, Inc. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.97 - $1.77 $48,290 - $88,117	49,784 New	49,784 $51,000
Q4 2021 Feb 17, 2022	SELL	$2.68 - $4.46 $44,817 - $74,584	-16,723 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.5 - $3.53 $41,807 - $59,032	16,723 New	16,723 $55,000
Q2 2021 Sep 17, 2021	SELL	$2.36 - $3.2 $62,450 - $84,678	-26,462 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$2.6 - $4.16 $13,652 - $21,844	5,251 Added 24.76%	26,462 $83,000
Q4 2020 Feb 24, 2021	SELL	$2.19 - $2.96 $20,003 - $27,036	-9,134 Reduced 30.1%	21,211 $56,000
Q3 2020 Dec 11, 2020	BUY	$1.62 - $4.24 $26,307 - $68,853	16,239 Added 115.12%	30,345 $81,000
Q2 2020 Aug 07, 2020	BUY	$1.19 - $2.27 $16,786 - $32,020	14,106 New	14,106 $28,000
Q3 2019 Nov 20, 2019	SELL	$2.15 - $3.36 $34,522 - $53,951	-16,057 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.75 - $5.0 $44,156 - $80,285	16,057 New	16,057 $49,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $299M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.